was read the article
array:23 [ "pii" => "S0300289622005154" "issn" => "03002896" "doi" => "10.1016/j.arbres.2022.08.008" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "3169" "copyright" => "SEPAR" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2023;59:44-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0300289622005944" "issn" => "03002896" "doi" => "10.1016/j.arbres.2022.10.006" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "3203" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2023;59:46-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>" "titulo" => "Effectiveness of Physiotherapy Intervention in Case of Extended Dengue Syndrome: An Undocumented Case Study" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "46" "paginaFinal" => "47" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1000 "Ancho" => 3175 "Tamanyo" => 150509 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Differences in ranges of chest expansion and incentive spirometry from day 1st to day 5th.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jaishree Rai, Amit Kumar" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Jaishree" "apellidos" => "Rai" ] 1 => array:2 [ "nombre" => "Amit" "apellidos" => "Kumar" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289622005944?idApp=UINPBA00003Z" "url" => "/03002896/0000005900000001/v3_202311210639/S0300289622005944/v3_202311210639/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S0300289622005129" "issn" => "03002896" "doi" => "10.1016/j.arbres.2022.08.005" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "3166" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Arch Bronconeumol. 2023;59:36-43" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "Hypoxic Burden in Obstructive Sleep Apnea: Present and Future" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "36" "paginaFinal" => "43" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1514 "Ancho" => 1675 "Tamanyo" => 142922 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Adjusted survival curves for cardiovascular mortality across categories of the hypoxic burden in Osteoporotic Fractures in Men Study (MrOS).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Miguel A. Martinez-Garcia, Manuel Sánchez-de-la-Torre, David P. White, Ali Azarbarzin" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Miguel A." "apellidos" => "Martinez-Garcia" ] 1 => array:2 [ "nombre" => "Manuel" "apellidos" => "Sánchez-de-la-Torre" ] 2 => array:2 [ "nombre" => "David P." "apellidos" => "White" ] 3 => array:2 [ "nombre" => "Ali" "apellidos" => "Azarbarzin" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289622005129?idApp=UINPBA00003Z" "url" => "/03002896/0000005900000001/v3_202311210639/S0300289622005129/v3_202311210639/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>" "titulo" => "Bilateral Significant Pneumotorax During Pazopanib Treatment" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "44" "paginaFinal" => "45" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Ahmet Gulmez" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Ahmet" "apellidos" => "Gulmez" "email" => array:1 [ 0 => "doktor.ahmetgulmez@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor1" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Adana City Education and Research Hospital, Medical Oncology Department, Adana, Turkey" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 850 "Ancho" => 1505 "Tamanyo" => 146699 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Bilateral significant pneumothorax and bilateral lung metastases.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Secondary spontaneous pneumothorax always develops secondary to underlying lung disease. Although its occurrence due to cancer is rare, it is mainly related to sarcomas. Bilateral pneumothorax is less common. Pazopanib, used in the treatment of sarcoma patients, is also a cause of pneumothorax. Pazopanib, a tyrosine kinase inhibitor, is frequently used for renal cell carcinoma, pancreatic neuroendocrine tumors, and especially soft tissue sarcomas. Pneumothorax cases due to pazopanib have been reported in the literature.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">An 18-year-old male patient was admitted to the hospital with a palpable approximately 10<span class="elsevierStyleHsp" style=""></span>cm mass lesion on the lateral side of the gastrocnemius muscle of the left lower extremity. The mass of the patient who did not detect distant metastases as a result of positron emission tomography (PET/CT) was surgically excised. As a result of the pathological evaluation of the material removed after the operation, it was reported that the mass was synovial sarcoma. Six courses of IMA (ifosfamide, mesna, adriamycin) treatment was planned. Six months after the completion of adjuvant therapy, multiple lung nodules were detected on thoracic computed tomography (CT). New systemic treatment was planned for the patient for recurrent synovial sarcoma. Primary granulocyte colony-stimulating factor (G-CSF) prophylaxis with gemcitabine and docetaxel treatment was planned as second-line chemotherapy. Despite the primary prophylaxis, the patient could not tolerate chemotherapy due to deepening bi-cytopenia, and the patient's systemic treatment was discontinued due to toxicity. Pazopanib was started as a third-line treatment. The radiologic evaluation was performed after 3 months of treatment in the patient, who did not detect any toxicity with pazopanib treatment and did not have any complaints. Bilateral significant pneumothorax was detected in the CT performed to evaluate the response. Diffuse bilateral pneumothorax is shown in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>. Despite bilateral significant pneumothorax, the patient did not have any clinical deterioration. The patient was treated with tube thoracostomy and he was discharged after five days of hospitalization. Pazopanib was restarted at 400<span class="elsevierStyleHsp" style=""></span>mg/day for two weeks after discharge. Systemic treatment of the patient who developed pneumothorax again after one week of pazopanib use was completely discontinued.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Soft tissue sarcomas metastasize quite frequently. The lung is an important site of metastasis. Unfortunately, treatment options are limited in metastatic soft tissue sarcomas. Pazopanib is an effective treatment option for these patients. In a pre-approved clinical study of pazopanib for metastatic soft tissue sarcoma, the incidence of pneumothorax during pazopanib treatment was reported to be approximately 2%.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> However, higher pneumothorax rates (∼10%) have also been reported in more recent studies.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> The mechanism of secondary pneumothorax arising from lung metastases is not clear. However, various theories such as tumor necrosis, check valve and tumor embolism have been reported.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> In addition, it is well known that angiogenesis inhibitors cause tumor necrosis and cavitation in lung lesions.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> Pazopanib can also cause pneumothorax by using this mechanism of action. Especially in sarcoma patients with diffuse lung metastases, routine lung examination and chest X-ray should be planned even if there are no symptoms while using pazopanib treatment.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0020" class="elsevierStylePara elsevierViewall">No funders pertaining to this article.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 850 "Ancho" => 1505 "Tamanyo" => 146699 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Bilateral significant pneumothorax and bilateral lung metastases.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pneumothorax during pazopanib treatment in patients with soft-tissue sarcoma: two case reports and a review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Nakahara" 1 => "T. Fukui" 2 => "K. Katono" 3 => "Y. Nishizawa" 4 => "Y. Okuma" 5 => "M. Ikegami" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000463380" "Revista" => array:5 [ "tituloSerie" => "Case Rep Oncol" "fecha" => "2017" "volumen" => "10" "paginaInicial" => "333" "paginaFinal" => "338" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.T. Van der Graaf" 1 => "J.Y. Blay" 2 => "S.P. Chawla" 3 => "D.W. Kim" 4 => "B. Bui-Nguyen" 5 => "P.G. Casali" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Lancet" "fecha" => "2012" "volumen" => "379" "paginaInicial" => "1879" "paginaFinal" => "1886" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Nakano" 1 => "L. Inagaki" 2 => "J. Tomomatsu" 3 => "N. Motoi" 4 => "T. Gokita" 5 => "K. Ae" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clon.2014.02.010" "Revista" => array:4 [ "tituloSerie" => "Clin Oncol (R Coll Radiol)" "fecha" => "2014" "volumen" => "26" "paginaInicial" => "357" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spontaneous pneumothorax in metastatic thyroid papillary carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.J. Lee" 1 => "E.K. Kim" 2 => "J.K. Min" 3 => "Y.K. Jin" 4 => "S.W. Hong" 5 => "S.P. Cheong" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO. 2007.11.0130" "Revista" => array:5 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2007" "volumen" => "25" "paginaInicial" => "2616" "paginaFinal" => "2618" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.J. Crabb" 1 => "D. Patsios" 2 => "E. Sauerbrei" 3 => "P.M. Ellis" 4 => "A. Arnold" 5 => "G. Goss" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO. 2008.16.2545" "Revista" => array:5 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2009" "volumen" => "27" "paginaInicial" => "404" "paginaFinal" => "410" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/03002896/0000005900000001/v3_202311210639/S0300289622005154/v3_202311210639/en/main.assets" "Apartado" => array:4 [ "identificador" => "93865" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case reports" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005900000001/v3_202311210639/S0300289622005154/v3_202311210639/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289622005154?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 56 | 27 | 83 |
2024 September | 85 | 26 | 111 |
2024 August | 91 | 42 | 133 |
2024 July | 81 | 15 | 96 |
2024 June | 77 | 24 | 101 |
2024 May | 77 | 21 | 98 |
2024 April | 58 | 23 | 81 |
2024 March | 49 | 22 | 71 |
2024 February | 104 | 35 | 139 |
2024 January | 60 | 32 | 92 |
2023 December | 60 | 22 | 82 |
2023 November | 63 | 21 | 84 |
2023 October | 75 | 33 | 108 |
2023 September | 73 | 33 | 106 |
2023 August | 58 | 37 | 95 |
2023 July | 85 | 29 | 114 |
2023 June | 80 | 17 | 97 |
2023 May | 59 | 24 | 83 |
2023 April | 62 | 30 | 92 |
2023 March | 79 | 29 | 108 |
2023 February | 109 | 35 | 144 |
2023 January | 173 | 96 | 269 |
2022 December | 107 | 21 | 128 |